Nuveen Asset Management’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $47.6M | Sell |
304,115
-7,740
| -2% | -$1.21M | 0.01% | 671 |
|
|
2024
Q3 | $56.8M | Sell |
311,855
-24,315
| -7% | -$4.43M | 0.02% | 598 |
|
|
2024
Q2 | $61.7M | Buy |
336,170
+5,728
| +2% | +$1.05M | 0.02% | 542 |
|
|
2024
Q1 | $58.8M | Buy |
330,442
+14,977
| +5% | +$2.66M | 0.02% | 576 |
|
|
2023
Q4 | $39.1M | Buy |
315,465
+53,231
| +20% | +$6.6M | 0.01% | 729 |
|
|
2023
Q3 | $30.4M | Buy |
262,234
+111,395
| +74% | +$12.9M | 0.01% | 793 |
|
|
2023
Q2 | $17.7M | Buy |
150,839
+97,908
| +185% | +$11.5M | 0.01% | 1150 |
|
|
2023
Q1 | $4.24M | Sell |
52,931
-4,481
| -8% | -$359K | ﹤0.01% | 1984 |
|
|
2022
Q4 | $4.55M | Sell |
57,412
-27,913
| -33% | -$2.21M | ﹤0.01% | 1967 |
|
|
2022
Q3 | $5.95M | Sell |
85,325
-31
| -0% | -$2.16K | ﹤0.01% | 1800 |
|
|
2022
Q2 | $5.6M | Buy |
85,356
+1,097
| +1% | +$72K | ﹤0.01% | 1874 |
|
|
2022
Q1 | $5.64M | Buy |
84,259
+6,081
| +8% | +$407K | ﹤0.01% | 1991 |
|
|
2021
Q4 | $5.47M | Sell |
78,178
-4,122
| -5% | -$288K | ﹤0.01% | 2066 |
|
|
2021
Q3 | $4.3M | Buy |
82,300
+14,090
| +21% | +$736K | ﹤0.01% | 2298 |
|
|
2021
Q2 | $4.64M | Buy |
68,210
+15,914
| +30% | +$1.08M | ﹤0.01% | 2294 |
|
|
2021
Q1 | $4.03M | Buy |
52,296
+4,105
| +9% | +$316K | ﹤0.01% | 2269 |
|
|
2020
Q4 | $2.89M | Buy |
48,191
+1,217
| +3% | +$73K | ﹤0.01% | 2324 |
|
|
2020
Q3 | $2.02M | Buy |
46,974
+2,774
| +6% | +$119K | ﹤0.01% | 2383 |
|
|
2020
Q2 | $1.83M | Buy |
44,200
+2,524
| +6% | +$105K | ﹤0.01% | 2373 |
|
|
2020
Q1 | $1.8M | Buy |
41,676
+2,189
| +6% | +$94.6K | ﹤0.01% | 2242 |
|
|
2019
Q4 | $2.19M | Sell |
39,487
-1,145
| -3% | -$63.4K | ﹤0.01% | 2387 |
|
|
2019
Q3 | $1.41M | Buy |
40,632
+5,450
| +15% | +$189K | ﹤0.01% | 2548 |
|
|
2019
Q2 | $1.42M | Buy |
+35,182
| New | +$1.42M | ﹤0.01% | 2591 |
|